|
|
 |
|
Viewing report
|
|
|
|
Astellas Pharma Inc.: Company Profile and SWOT Analysis
iCD Research, Sep 2011, Pages: 42
Synopsis
ICD Research's 'Astellas Pharma Inc.: Company Profile and SWOT Analysis' contains in depth information and data about the company and its operations. The profile contains a company overview, business description, financial ratios, SWOT analysis, key facts, information on products and services, details of locations and subsidiaries, plus information on key news events affecting the company.
Summary
This SWOT analysis and company profile is a crucial resource for industry executives and anyone looking to gain a better understanding of the company's business.
ICD Research's 'Astellas Pharma Inc.: Company Profile and SWOT Analysis' report utilizes a wide range of primary and secondary sources, which are analyzed and presented in a consistent and easily accessible format.
ICD Research strictly follows a standardized research methodology to ensure high levels of data quality and these characteristics guarantee a unique report.
Scope
- Examines and identifies key information and issues about Astellas Pharma Inc. for business intelligence requirements
- Studies and presents the company's strengths, weaknesses, opportunities (growth potential) and threats (competition). Strategic and operational business information is objectively reported
- Provides analysis on financial ratios of the company
- The profile also contains information on business operations, company history, major products and services, prospects, key competitors, key employees, locations and subsidiaries
Reasons To Buy
- Quickly enhance your understanding of the company
- Gain insight into the marketplace and a better understanding of internal and external factors which could impact the industry
- Increase business/sales activities by understanding your competitors’ businesses better
- Recognize potential partnerships and suppliers
- Obtain yearly profitability figures
Key Highlights
Astellas Pharma Inc. (Astellas) is a global pharmaceutical company engaged in developing, manufacturing and marketing of pharmaceuticals and related products. The company has superior research and development capabilities to develop new drugs, manufacturing facilities for the manufacturing of products in a cost effective way and efficient in-house sales force to market those products. Its global major products are Prograf, Vesicare, Protopic, Harnal and Funguard. The company is one of the leading pharmaceutical manufacturers providing products for Urology, transplantation and Oncology fields. Apart from Japan, Astellas supplies its products to global markets, including Ireland, the UK, Netherlands, China, Hong Kong, Thailand, Indonesia, Philippines, etc. The company is headquartered at Chuo-Ku in Tokyo, Japan.
|
|
|
|
